EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY-NC 4.0

Prevalence, Incidence, and Mortality of Myasthenia Gravis and Myasthenic Syndromes: A Systematic Review

Francesco Sciancalepore, Francesco Sciancalepore, Niccolò Lombardi, Giulia Valdiserra, Marco Bonaso, Emiliano Cappello, Giulia Hyeraci, Giada Crescioli, Maria Grazia Celani, Teresa Anna Cantisani, Paola Brunori, Simona Vecchi und 5 weitere

Neuroepidemiology · 09.10.2024 · 59 (5) · 579-592

DOI: 10.1159/000539577 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Neuroepidemiology, online erschienen am 09.10.2024. Verfasst von Francesco Sciancalepore und 16 weiteren Autor:innen. Beteiligte Einrichtung: National Center for Disease Prevention and Health Promotion, Italian National Institute of Health, Rome, Italy. Hauptthemen laut MEDLINE: Myasthenia Gravis. Die Arbeit wurde bisher 52-mal zitiert (Crossref) und nennt 112 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

No systematic reviews were published in the last years investigating epidemiological data, involving myasthenia gravis (MG) and related myasthenic syndromes. This systematic review aimed to estimate the prevalence, incidence, and mortality of all MG types and myasthenic syndromes worldwide.

Methods

All literature published up to February 2024 was retrieved by searching the databases “Medline,” “Embase,” “ISI Web of Science” and “CINAHL” using the following search terms: (epidemiolog* OR frequency OR prevalence OR incidence OR mortality) AND (myasth* OR “anti-acetylcholine receptor antibody” OR “AChR” OR “MuSK” OR “anti-muscle specific kinase antibody” OR “LRP4” OR “seronegative MG”).

Results

A total of 94 studies, performed between 1952 and 2022, were included. Prevalence of MG ranged from 20 to 475 cases per million, with a mean prevalence of 173.3 (95% confidence interval [CI]: 129.7–215.5) cases per million and a median prevalence of 129.6 cases per million. Incidence rates ranged from 2.3 to 61.3 cases per million person-years, with a mean incidence of 15.7 (95% CI: 11.5–19.9) and a median of 13.3 cases. Mortality rates showed a mean of 1.4 (95% CI: 0.8–2.1) cases per million person-years. Acetylcholine receptor (AChR)-MG was the clinical subtype more frequent in terms of prevalence and incidence.

Discussion

The prevalence and incidence of MG have significantly increased over the last years worldwide, probably due to the improvement of epidemiological methodologies and current advances in diagnosis. However, we observed a significant variation in frequencies of MG between and within countries because of methodological biases and complex heterogeneity of the disease characterized by several phenotypes and different clinical responses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myasthenia GravisHumansPrevalenceIncidence

Stichwörter der Autor:innen

EpidemiologyIncidenceMortalityMyasthenia gravisPrevalence

Autor:innen und Institutionen

  • National Center for Disease Prevention and Health Promotion, Italian National Institute of Health, Rome, Italy.
  • Department of Human Neuroscience, Sapienza University of Rome, Rome, Italy.
  • Department of Neuroscience, Psychology, Drug Research and Child Health, University of Florence, Florence, Italy.
  • Unit of Pharmacology and Pharmacovigilance, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
  • Regional Health Agency of Tuscany, Pharmacoepidemiology Unit, Florence, Italy.
  • Neurophysiopathology, Perugia Hospital, Perugia, Italy.

Zitieren

APA

Sciancalepore, F., Sciancalepore, F., Lombardi, N., Valdiserra, G., Bonaso, M., Cappello, E., Hyeraci, G., Crescioli, G., Celani, M. G., Cantisani, T. A., Brunori, P., Vecchi, S., Bacigalupo, I., Locuratolo, N., Lacorte, E., Vanacore, N., & Kirchmayer, U. (2024). Prevalence, Incidence, and Mortality of Myasthenia Gravis and Myasthenic Syndromes: A Systematic Review. Neuroepidemiology, 59(5), 579-592. https://doi.org/10.1159/000539577

Vancouver

Sciancalepore F, Sciancalepore F, Lombardi N, Valdiserra G, Bonaso M, Cappello E, et al. Prevalence, Incidence, and Mortality of Myasthenia Gravis and Myasthenic Syndromes: A Systematic Review. Neuroepidemiology. 2024;59(5):579-592. doi:10.1159/000539577

BibTeX
@article{Sciancalepore2024,
  author = {Sciancalepore, Francesco and Sciancalepore, Francesco and Lombardi, Niccolò and Valdiserra, Giulia and Bonaso, Marco and Cappello, Emiliano and Hyeraci, Giulia and Crescioli, Giada and Celani, Maria Grazia and Cantisani, Teresa Anna and Brunori, Paola and Vecchi, Simona and Bacigalupo, Ilaria and Locuratolo, Nicoletta and Lacorte, Eleonora and Vanacore, Nicola and Kirchmayer, Ursula},
  title = {Prevalence, Incidence, and Mortality of Myasthenia Gravis and Myasthenic Syndromes: A Systematic Review},
  journal = {Neuroepidemiology},
  year = {2024},
  volume = {59},
  number = {5},
  pages = {579--592},
  doi = {10.1159/000539577}
}
Kostenlos starten →